molecular diagnostics

Entovations bridges cutting-edge research and real-world agricultural innovation, empowering agricultural producers, researchers, and innovators by decoding insect biology and connecting multi-omics research with agricultural impact. The company offers consultation and project design, next-generation sequencing and data analysis, and molecular diagnostics and performance analysis.

bioinformatics analysisconsultation and project designgenomic profilingshort- and long-read DNA/RNA sequencing

EpigenoMax Therapeutics is developing an integrated precision oncology platform that combines molecular diagnostics with programmable BioGene therapeutics. The company aims to overcome treatment resistance and improve outcomes for patients with difficult-to-treat cancers by selectively targeting malignant cells while minimizing effects on healthy tissue. Its molecular diagnostic technologies are designed to detect cancers at the molecular level to personalize therapy and guide treatment decisions.

precision oncology researchtargeted BioGene therapeutics

Eurofins Transplant Genomics is committed to improving organ transplant outcomes with noninvasive diagnostics guided by genetic biomarkers. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy for kidney and liver transplant recipients.

donor-derived cell-free DNA (dd-cfDNA) testinggene expression profilingliquid biopsynoninvasive rejection monitoring

GenEndeavor develops novel technology platforms for the early detection of genetic and infectious diseases and for cost-effective trait screening in healthcare and agriculture. Its assay technology platforms aim to enable sensitive, rapid, and affordable point-of-care testing by lowering the detection limit of rare mutations and pathogens. The company is also developing an accessible diagnostic tool for early detection of ovarian cancer and diagnostic solutions for TB patients.

assay technology platformsearly disease detectionNon-Enzymatic Amplification Technologies (NEAT)point of care testing

Genetic Signatures is a specialist molecular diagnostics company founded in 2001 by Dr Geoffrey Grigg. It develops and commercialises its proprietary 3base technology, the cornerstone of its EasyScreen Pathogen Detection Kits, providing hospitals and pathology laboratories with molecular tools to screen for infectious pathogens in a rapid high-throughput environment. The company is ISO 13485 certified and headquartered in Newtown, Sydney, Australia.

multiplex PCRreagent production and assemblyreal-time PCR assay developmentresearch and developmentsample processing

iGenomeDx is a molecular diagnostics laboratory in San Antonio, TX, providing full spectrum molecular diagnostics services including genetic testing and drug monitoring. It offers pharmacogenomics test panels, infectious disease testing, and oral and urine toxicology, aiming to provide fast and accurate precision diagnostics for personalized care. It was awarded 2022 Minority-Owned Small Business of the Year by the U.S. and is a Gold Sponsor of the Bexar County Medical Society.

drug monitoringgenetic testingliquid chromatography-mass spectrometry (LCMS)polymerase chain reaction (PCR)

Immunexpress is a privately-owned molecular diagnostic company founded in Australia, with offices in Seattle, USA, and Brisbane, Australia. It develops and commercializes SeptiCyte® technology, which rapidly detects sepsis by analyzing a patient's immune response (host response) rather than pathogens. Its SeptiCyte® RAPID cartridge, compatible with the Biocartis Idylla™ platform, produces clinically actionable results in one hour.

clinical trials validationgene expression quantification and analysis from whole bloodhost immune response technology

InBios International, Inc. is a privately owned biotechnology company based in Seattle, Washington, founded in 1996. It designs, develops and manufactures immunodiagnostic devices and in vitro diagnostic tests for infectious diseases and biothreats, with over 25 diagnostic products and a catalog of life science reagents. Products are manufactured in the USA; the company is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified.

assay developmentcontract manufacturingdesign and development of immunodiagnostic devicesdevelopment and manufacture of antibodies and antigensELISAmanufacture of in vitro diagnostic testsrapid immunoassays

multiplex molecular solution for diagnosis of human diseases A multiplex molecular solution for diagnosis of human diseases Our Company KASA BIO is a molecular diagnostics company developing a proprietary high multiplex probe technology for the targeted detection of nucleic acid biomarkers. Our vision is to provide simple and inexpensive solutions for diagnosis of complex diseases using well adopted PCR technology. Founders have extensive experience in molecular biology and molecular diagnostics. Diagnostic Challenges Various infectious and oncological diagnostic applications require analysis of multiple DNA or RNA biomarkers. Lack of availability of a quantitative multiplex platform for analysis of gene expression and mi RNA signature analysis. Lack of availability of a tool for analysis of multiple biological specimens at resource limited setting. Requirement of larger sample volume.

digital PCRisothermal amplificationmultiplex probe technologynucleic acid biomarker detectionqPCR

Kashi Clinical Laboratories is a CLIA-licensed, CAP and ASHI accredited laboratory in Portland, Oregon, with over 20 years of experience as a partner and industry leader in histocompatibility, immunogenetics, and advanced translational diagnostics. It provides clinical pathology, genomics, HLA and transplant testing, toxicology, virology, and pharma services supporting cell and gene therapy and CAR-T development.

biorepository storageclinical chemistryclinical trial supporthematology and coagulationhistocompatibility testingimmunogeneticsimmunology and serologymethod development and validationmicrobiology and virology testingRNA expression analysistoxicology and drug monitoring